Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2019-10-28 | Dr. Day has almost twenty (20) years’ experience in R&D and business development in the biotech industry. The Company believes Dr. Day’s experience in technology scouting and licensing at pharmaceutical and biotech publicly traded companies, with expertise in research and business development, render him qualified to serve as a member of the Board of Directors. |
| 2020-02-19 | Mark Day 727 * % 0 0 % * % |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22